Exclusive package for cryo shipping from UK and USA for surrogacy with Home Office and AABB Approved legal DNA Lab testing services for parental orders. Available in our Clinic with Greenplace Healthcare!
UK, USA, and Africa's Leader in Secure and Reliable Dedicated Cryogenic Medical Transport owned and led by Biomedical Scientists.
15+
Years of Experience
100%
Success Rate
2155+
Handy Carry Transports
53+
Countries Delivered
Your Trusted Partner in Secure, Safe, and Reliable Cryogenic Transport
Cryogenic Material Transport
Cryo Medical Logistics, a division of Greenplace Healthcare—an ISO 9001:2015 certified company—specializes in the secure and efficient hand-carry and cargo transport of cryogenic reproductive and pharmaceutical materials. Our expert team ensures the integrity and viability of these critical biological samples are maintained throughout every stage of the logistics process.
Customised Logistics and Pricing Solutions
We understand the unique requirements of transporting cryogenic materials. We customize each shipment to meet your specific needs, offering tailored logistics solutions that guarantee the secure and timely delivery of sensitive medical materials. For frequent shipments with cryo banks, we provide flexible pricing options designed to support ongoing partnerships.
Specialised Logistics Software and Insurance
Utilizing specialized cutting-edge software with live map tracking and real-time temperature monitoring technology, we ensure optimal conditions throughout the cryogenic transport of biological materials, safeguarding their preservation and quality at every stage.
Compliance
At Cryo Medical Logistics, we are committed to providing the highest level of service and maintaining compliance with all relevant industry regulations and standards. We follow the guidelines set forth by leading organizations to ensure the safe, secure, and efficient transport of biological materials, including cryogenic shipments.
Federal Ministry of
Health Nigeria
HFEA UK
EU Tissue and Cells Directive (2004/23/EC)
U.S. Food and Drug Administration
